Products - Lipid disorders | Topic | NICE

Showing 5 products

Date | Title

Guidance programme: Highly specialised technologies guidanceRemove ‘Guidance programme: Highly specialised technologies guidance’ filter

Sebelipase alfa for treating Wolman disease (HST30)
Product type:
Guidance
Programme:
Highly specialised technologies guidance
Published:
10 January 2024
Metreleptin for treating lipodystrophy (HST14)
Product type:
Guidance
Programme:
Highly specialised technologies guidance
Published:
24 February 2021
VTS-270 for treating Niemann-Pick type C1 [ID1267]
Status:
In development
Programme:
Highly specialised technologies guidance
Expected publication date:
TBC
Arimoclomol for treating Niemann-Pick disease Type C [ID1312]
Status:
In development
Programme:
Highly specialised technologies guidance
Expected publication date:
TBC
Olipudase alfa for treating Niemann-Pick disease types A and B [ID3913 ]
Status:
In development
Programme:
Highly specialised technologies guidance
Expected publication date:
TBC